Oxidative stress and bone mineral density in elderly men: Antioxidant activity of alpha-tocopherol a b s t r a c t a r t i c l e i n f o Oxidative stress has recently been identified as a pivotal pathogenetic factor of bone loss in mice, but its importance in humans is not clear. We aimed to investigate the association between urinary 8-iso-PGF 2α levels, a major F 2 -isoprostane and a reliable in vivo biomarker of oxidative stress, and bone mineral density (BMD), and to study whether vitamin E in the form of serum α-tocopherol, a scavenger of peroxyl radicals, modifies the association. In 405 men, urinary 8-iso-PGF 2α and serum α-tocopherol were measured at age 77 years and BMD at age 82 years. One SD increase in 8-iso-PGF 2α corresponded to an approximately 2-4% decrease in average adjusted BMD values of total body, lumbar spine, and proximal femur (all P b 0.001). Serum α-tocopherol levels seemed to modify the association between urinary 8-iso-PGF 2α and BMD. Men with α-tocopherol levels below the median combined with high oxidative stress, i.e., 8-iso-PGF 2α above the median, had 7% (95% CI 3-11%) lower BMD at the lumbar spine and 5% (95% CI 2-9%) lower BMD at the proximal femur. In elderly men high oxidative stress is associated with reduced BMD, which is more pronounced in individuals with low serum levels of the antioxidant vitamin E.
Introduction
Our skeleton is constantly renewed at an average rate of 10% per year. Osteoporosis is a disease resulting from a decreased renewal of bone, which leads to a fragile skeleton and increased risk of fractures. The etiology of osteoporosis is complex and the fracture risk is influenced both by the genetic constitution and by environmental factors, with lifestyle becoming more important for bone mass and osteoporotic fractures with increasing age [1, 2] .
Oxidative stress, which presumably increases with age [3] , is a condition of excess formation of free radicals either by physiological or pathophysiological processes and states of insufficient antioxidative defense. Free radicals are involved in osteoblastogenesis [4, 5] , in apoptosis of osteoblasts and osteocytes and in osteoclastogenesis and therefore also in bone resorption as shown in animal and in vitro studies [6] . These experimental data clearly establish a biological link between oxidative stress and bone [7] .
A central problem associated with the assessment of free radicalinduced oxidative stress in disease development has been the limitation in existing assay methods for in vivo measurement of free radical generation [8] . F 2 -Isoprostanes, structural isomers of PGF 2α , are formed during free-radical catalysed peroxidation of arachidonic acid [9] . A major F 2 -isoprostane, 8-iso-PGF 2α , is now a well-recognised reliable indicator of oxidative stress in vivo [10] [11] [12] . Indeed, we have shown that there is a biochemical link between increased oxidative stress as measured by urinary 8-iso-PGF 2α and reduced bone density at some sites in a small population-based study [13] . These results have recently been confirmed and extended in a study showing that serum levels of 8-iso-PGF 2α among both hypercholesterolemic patients and hospital-based controls display an inverse correlation with bone formation markers and with bone mineral density (BMD) at the femoral neck but not at the lumbar spine [14] . The paucity of previous human studies examining the association between oxidative stress and BMD and the unstable estimates in these few studies call for new studies with a preferentially larger study size.
Vitamin E scavenges peroxyl radicals [15] . It is a lipid-soluble antioxidant present in plasma and mainly stored in the liver. Plasma concentrations of vitamin E in humans are tightly regulated and partially genetically determined [16, 17] with surprisingly small influential effects of the dietary intake of vitamin E [18] . α-Tocopherol is the most abundant form of vitamin E in human tissues and serum and has the greatest biological activity [15, 17] . Administration of α-tocopherol has an effect on the isoprostane formation in various experimental models [19, 20] , but in human studies this effect is only observed at very high levels of supplementation [21] .
We aimed in a large prospective study to investigate the association between urinary 8-iso-PGF 2α levels at 77 years of age and BMD 4 years later. We hypothesised that the conceivable negative influence of oxidative stress measured by urinary 8-iso-PGF 2α on BMD is modified by serum α-tocopherol by virtue of its ability to scavenge free radicals. In this context we used a population-based cohort of elderly men to test this hypothesis.
Materials and methods

ULSAM -Uppsala Longitudinal Study of Adult Men
The Uppsala Longitudinal Study of Adult Men (http://www. pubcare.uu.se/ULSAM) has been described in detail elsewhere [22, 23] . Briefly, from 1970 to 1973, all 2841 men born in 1920-1924 and living in the municipality of Uppsala, Sweden, were invited to participate in a health survey. A total of 2322 men (82% of those invited), 49 to 51 years of age (age 50), agreed to participate. Four more evaluations have been performed: at 60 (n = 1,860), 70 (n = 1,221), 77 (n = 839), and 82 years of age (n = 530). The fourth evaluation at 77 years of age, when urine was collected over 24 h, forms the baseline for the present study. Both urine and plasma from the fourth evaluation were stored at -70°C until analyses. Urinary 8-iso-PGF 2α and 15-keto-dihydro-PGF 2α levels (an inflammatory response indicator) were available for 706 (84%) of these men. At each investigation participants provided blood samples and answered a questionnaire regarding medical history, lifestyle habits, and regular medication. The study was approved by the Ethics Committee of Uppsala University. All participants gave written informed consent.
Assay of F 2 -isoprostanes (oxidative stress indicator)
Urinary samples were analysed for 8-iso-PGF 2α , a major F 2 -isoprostane, by a specific and validated radioimmunoassay at our laboratory as described in detail elsewhere [24] . The detection limit of the 8-iso-PGF 2α assay was 23 pmol/L. The urinary levels of 8-iso-PGF 2α were adjusted for urinary creatinine concentration (UCC). The intraassay coefficient of variation (CV) was 14.5% at low concentrations and 12.2% at high concentrations.
15-Keto-dihydro-PGF 2α (inflammatory response indicator)
Urinary samples were analysed for 15-keto-dihydro-PGF 2α , a major metabolite of primary PGF 2α , by a specific and validated radioimmunoassay at our laboratory as described previously [25] . The urinary levels of 15-keto-dihydro-PGF 2α were adjusted for UCC. The intraassay CV was 12.2% at low concentrations and 14.0% at high concentrations.
Serum α-tocopherol
Serum α-tocopherol was analysed using high performance liquid chromatography (HPLC) and fluorescence detection with a Hitachi pump and LiChrospher 100 NH2 250 × 4-mm column [26] . The serum tocopherol levels were adjusted for the sum of the total serum cholesterol and triglyceride concentration (tocopherol/ (cholesterol+triglyceride)) [27] . The intraassay CV for the method was 4.5%.
Dual-energy X-ray absorptiometry (DXA)
At the fifth ULSAM investigation at age 82, on average 4 years after the analysis of oxidative stress levels by 8-iso-PGF 2α , 507 men agreed to undergo measurements of BMD of the total body, proximal femur, and lumbar spine (vertebrae L2-L4), as well as total lean and fat mass by DXA (DPX Prodigy, Lunar Corp., Madison, WI, USA). When applicable, both extremities were used in the calculation. By triple measurements in 15 participants, the precision error of the DXA measurements in our laboratory has been calculated to be between 0.8 and 1.5% for BMD depending on site and between 0.7 and 1.6% for bone areas. Total fat mass had a precision error of 1.5% and total lean mass 1.0%.
Totally, 405 men from the general population underwent measurement for both 8-iso-PGF 2α and serum α-tocopherol at age 77 years and they had their BMD measured by DXA at age 82 years. These men constitute the study base for the present investigation.
Statistical analysis
All statistical calculations were performed using SAS (SAS 9.1, SAS Institute, Cary, NC, USA). We used standard linear regression models to examine the relationship between 8-iso-PGF 2α , as expressed per standard deviation increase in urine values, and BMD. A normal probability plot of the residuals indicated no deviation from a linear pattern, as also indicated by Shapiro-Wilk tests with w ≥ 0.99. The variables were thus kept in their original continuous form. A potential nonlinear association was examined by introduction of a quadratic term of 8-iso-PGF 2α in the regression model. Smoking, obesity, and type 2 diabetes could be regarded as confounders but their effect on BMD may also be mediated by oxidative stress. Therefore, two models were used in the analyses: an age-adjusted model, including age at entry and end of follow-up (at time of the bone scan), and a multivariable model that included, in addition to age, counting height and weight (both at baseline and study end), total fat mass, total lean mass, 15-keto-dihydro-PGF 2α /creatinine ratio (as a valid measure on degree of inflammation) [25] , and the following categorical variables at both baseline and at end of follow-up: smoking status (never, former, current), leisure physical activity (low, intermediate, high), hypertension (yes/no), current oral cortisone use (yes/no), and diabetes mellitus (yes/no). We additionally had the possibility of adjusting our estimates for plasma vitamin D levels, calcium intake, vitamin D intake, vitamin C intake, alcohol intake, and calcium and vitamin D supplemental use. These variables were measured at a prior investigation, at age 71 years. Dietary and supplemental intakes were recorded in a 7-day dietary record. Nutrients were calculated with the use of data from the Swedish National Food Administration [28] . Plasma 25-hydroxyvitamin D was determined with high-pressure liquid chromatography (HPLC) atmospheric pressure chemical ionisation (APCI) mass spectrometry (MS) at Vitas, Oslo, Norway. None of these covariates influenced our estimates and they were therefore not included in the final multivariable model.
Exposure combinations of α-tocopherol and 8-iso-PGF 2α were constructed because we postulated that α-tocopherol modulated the association between 8-iso-PGF 2α and BMD. Forming four categories, levels below or above the median of α-tocopherol were combined with levels below or above the median of 8-iso-PGF 2α .
Results
Descriptive characteristics of the participants at baseline, at an average age of 77.5 years, by combinations of low (below the median) and high levels (above the median) of urinary 8-iso-PGF 2α and serum α-tocopherol are displayed in Table 1 . There were small differences between the categories in baseline values. Nevertheless, men with high α-tocopherol values and low oxidative stress values had a lower prevalence of diabetes mellitus.
As shown in Table 2 , urinary 8-iso-PGF 2α levels were negatively associated with total body, proximal femur, and lumbar spine BMD. One SD increase in 8-iso-PGF 2α levels corresponded to a decrease in average BMD values of about 2-4% depending on site. The parameter estimates were not substantially altered after multivariable adjustment. We did not discover any threshold effects because inclusion of a quadratic term of 8-iso-PGF 2α was far from statistically significant at all sites (P N 0.7).
Serum α-tocopherol levels seemed to modify the association between urinary 8-iso-PGF 2α and BMD (Fig. 1) . Elderly men with α-tocopherol levels below the median combined with a high degree of oxidative stress, i.e., 8-iso-PGF 2α levels above the median, had 7% (95% CI 3-11%) lower BMD at the lumbar spine and 5% (95% CI 2-9%) lower BMD at the proximal femur compared with the other participants. There was statistical interaction between 8-iso-PGF 2α and α-tocopherol for both the outcomes BMD at the lumbar spine (P = 0.04) and BMD at the proximal femur (P = 0.04).
No association was observed between serum α-tocopherol and BMD at our measured sites (Table 3) . Using Pearson's correlation coefficient, we also found only a weak correlation between urinary 8-iso-PGF 2α and serum α-tocopherol (r = 0.08, P = 0.04).
Discussion
The main finding of this study is the negative association among the oxidative stress marker urinary F 2 -isoprostane and BMD at the lumbar spine, the proximal femur, and of the total body, and that the association is further dependent on serum vitamin E level. We found only a modest association between urinary 8-iso-PGF 2α and serum α-tocopherol. This can be explained theoretically both by the vitamin's local cellular effect of stabilising membrane phospholipids from damage by free radicals [17] , with no or minor direct influence on systemic isoprostane levels at physiological levels of the vitamin [29] , and by the tight regulation of serum α-tocopherol [30] .
Oxidative stress may increase bone resorption through activation of nuclear factor-kappa β (NF-κβ) [32, 33] , which is part of the RANKL-OPG axis [31] that regulates osteoclast differentiation and thus bone resorption and remodeling. The immense significance of NF-κβ in osteoclastogenesis and bone turnover has recently been revealed by the discovery of osteopetrosis in mice lacking NF-κβ [34] and the identification of receptor activator of NF-κβ-(RANK), the RANK ligand, and the decoy receptor osteoprotegerin [35] . Of special interest in association with the present study, NF-κβ activates release of 8-isoprostane from fetal membranes in vitro. When these were treated with the potent free radical scavenger N-acetylcysteine, the release was inhibited [36] . Oxidative stress is a potential link between osteoporosis and known risk factors such as heart failure [37] , smoking [38] , and hypertension [39] and this link may at least partly be mediated by NF-κβ with its important role in modulating the expression of many genes involved in cell proliferation, differentiation, apoptosis, stress response, cell signalling transduction, inflammation, and other pathophysiological processes. Oxidative stress may also influence osteoblastogenesis and bone formation, where the Wnt-β-catenin pathway has emerged as a central regulator [40] . Recently, it was demonstrated that oxidative stress antagonises the skeletal effects of Wnt-β-catenin in vitro [4] . Thus, in summary, bone resorption can be activated and bone formation deactivated by oxidative stress.
Previously we suggested a biochemical link between increased oxidative stress, as measured by urinary F 2 -isoprostanes, and reduced BMD in humans [13] . In that smaller study involving 100 participants we showed that higher levels of urinary 8-iso-PGF 2α were related to lower BMD at peripheral sites of the skeleton. Our present investigation corroborates these earlier findings and adds to current knowledge by the inclusion of a larger number of participants, analysis of men only and participants of the same age, inclusion of several additional potential covariates in our models, and a clear negative association between urinary 8-iso-PGF 2α and BMD at all measured sites. Our investigation was performed within a well-established cohort of elderly men, the ULSAM. The results were independent of smoking, body composition, and cyclooxygenase-mediated inflammation status as measured by 15-keto-dihydro-PGF 2α in urine. In a diabetes mellitus rat model, 8-hydroxydeoxyguanosine, which is an oxidative stress marker, was remarkably elevated and associated with low turnover of bone [41] . Even though there was a higher prevalence of diabetes among those with high 8-iso-PGF 2α (Table 1) , our estimates were unaffected after adjustment for the diagnosis of diabetes mellitus. In a study from Italy [14] , serum levels of 8-iso-PGF 2α correlated negatively to lumbar spine and femoral neck BMD. A negative influence was also found between bone formation markers and oxidative stress, whereas bone resorption measured as carboxyterminal cross-linking telopeptide of type I collagen (CTX-I) did not display an association with serum 8-iso-PGF 2α . These findings indicate less of a role for the RANK-RANKL-OPG axis as a mediator of the negative influence of oxidative stress on bone. Furthermore, 8-iso-PGF 2α had no association with serum levels of RANKL and OPG. However, these modulators of bone resorption primarily exert their actions by paracrine effects on bone cells and thus the serum levels might not mirror these local activities. Our study also extends previous investigations by the possibility to determine the modifying influence of α-tocopherol, a potent scavenger of reactive oxygen species, on the association between 8-iso-PGF 2α and BMD. Trolox, a water-soluble vitamin E analogue, prevents osteoclast formation and bone loss by inhibiting both RANKL induction in osteoblasts and c-Fos expression in osteoclast precursors [42] . In an earlier study we established that an inadequate dietary intake of antioxidants increases considerably the risk of hip fracture in current smokers, whereas current smokers with a more adequate intake of antioxidants appear to have a fracture risk similar to that observed among never smokers [43] , supporting the theory that oxidative stress has important effects on bone in man. A low intake of antioxidants has also recently been associated with an increased hip fracture risk in women [44, 45] . It has as well been shown that osteoporotic women have lower serum antioxidant levels compared with controls [46] , and that higher intake of antioxidants may suppress bone resorption [47] and retard bone loss in some [48] [49] [50] [51] but not all [52] observational studies.
We acknowledge some additional strengths but also limitations. A free radical-mediated arachidonic acid oxidation leads to the formation of isoprostanes in vivo, and 8-iso-PGF 2α is currently recognized as the gold marker determinant of in vivo oxidative stress in both humans and animals [53, 54] . The measurement of 8-iso-PGF 2α in urine is considered to be more appropriate than in plasma when the basal levels are to be evaluated due to less fluctuation at higher basal levels in urine than in plasma [10] . In addition to having a valid measure of the exposure, our study has a favorable design regarding homogeneous age, gender, and ethnicity but has as such also the disadvantage of limited generalizability to other ethnic groups and women. Further, we studied survivors to the age of 82 years. These men had had a healthier lifestyle than the nonsurvivors of the cohort [55] which is also indicated by the low proportion of smokers and sedentary men among those who attained the DXA measurement at age 82 years. A possible healthy cohort effect would not lead to false positive results but instead tend to reduce the strength of the association between high oxidative stress and reduced BMD. Bone is constantly renewed at an average rate of 10% per year. The measurement of BMD was performed on average 4 years after the 24-h urine collection used for 8-iso-PGF 2α analysis. The optimal interval between exposure and outcome in this case is not known but given the rate of bone remodeling an induction period of 4 years seems to be reasonable.
In conclusion, this study demonstrates an association between isoprostane formation and reduced bone mineral density in a large well-characterized cohort. This association was of particular importance among men with low levels of serum α-tocopherol. of the bone scan), height and weight (both at baseline and at study end), total fat mass, total lean mass, 15-keto-dihydro-PGF 2α /creatinine ratio, and the following categorical variables at both baseline and at end of follow-up: smoking status (never, former, current), leisure physical activity (low, intermediate, high), cortisone use (yes/no), and diabetes (yes/no) at baseline.
